Organon & Co. (OGN)
13.79
+0.05
(+0.36%)
USD |
NYSE |
Oct 07, 16:00
13.78
-0.01
(-0.07%)
After-Hours: 20:00
Organon Price : 13.79 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 13.72 | 13.79 | 13.72 | 13.79 | 2.208M |
| Oct 06, 2026 | 13.74 | 13.75 | 13.73 | 13.74 | 1.949M |
| Oct 05, 2026 | 13.72 | 13.75 | 13.70 | 13.70 | 2.882M |
| Oct 02, 2026 | 13.71 | 13.75 | 13.71 | 13.72 | 1.921M |
| Oct 01, 2026 | 13.71 | 13.74 | 13.71 | 13.71 | 2.105M |
| Sep 30, 2026 | 13.74 | 13.76 | 13.70 | 13.70 | 2.066M |
| Sep 29, 2026 | 13.73 | 13.75 | 13.72 | 13.74 | 1.629M |
| Sep 28, 2026 | 13.75 | 13.75 | 13.72 | 13.73 | 1.990M |
| Sep 25, 2026 | 13.74 | 13.74 | 13.70 | 13.73 | 1.394M |
| Sep 24, 2026 | 13.72 | 13.74 | 13.72 | 13.72 | 2.215M |
| Sep 23, 2026 | 13.71 | 13.74 | 13.70 | 13.73 | 983340.0 |
| Sep 22, 2026 | 13.70 | 13.72 | 13.68 | 13.70 | 1.365M |
| Sep 21, 2026 | 13.70 | 13.76 | 13.67 | 13.68 | 3.116M |
| Sep 18, 2026 | 13.68 | 13.70 | 13.68 | 13.68 | 4.942M |
| Sep 17, 2026 | 13.67 | 13.69 | 13.66 | 13.69 | 1.263M |
| Sep 16, 2026 | 13.65 | 13.68 | 13.65 | 13.67 | 2.072M |
| Sep 15, 2026 | 13.65 | 13.68 | 13.65 | 13.66 | 3.594M |
| Sep 14, 2026 | 13.64 | 13.67 | 13.64 | 13.65 | 1.252M |
| Sep 11, 2026 | 13.65 | 13.65 | 13.63 | 13.64 | 1.728M |
| Sep 10, 2026 | 13.66 | 13.66 | 13.63 | 13.63 | 2.082M |
| Sep 09, 2026 | 13.78 | 13.78 | 13.64 | 13.67 | 5.565M |
| Sep 08, 2026 | 13.77 | 13.78 | 13.75 | 13.75 | 1.630M |
| Sep 04, 2026 | 13.76 | 13.78 | 13.76 | 13.78 | 4.872M |
| Sep 03, 2026 | 13.77 | 13.78 | 13.72 | 13.77 | 3.923M |
| Sep 02, 2026 | 13.77 | 13.78 | 13.76 | 13.77 | 3.626M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 142.79 |
| Pfizer Inc. | 28.00 |
| Bristol Myers Squibb Co. | 59.70 |
| Harmony Biosciences Holdings, Inc. | 39.34 |
| ANI Pharmaceuticals, Inc. | 71.93 |
Price Related Metrics
| PE Ratio | 17.67 |
| PS Ratio | 0.5932 |
| Price to Book Value | 3.600 |
| Price to Free Cash Flow | 6.513 |
| Earnings Yield | 5.66% |
| Market Cap | 3.621B |
| Operating PE Ratio | 3.057 |
| Normalized PE Ratio | 9.112 |